Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1754023

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1754023

HPV Testing and PAP Test Market Report by Test Type, Product, Application, End User, and Region 2025-2033

PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2999
PDF & Excel (5 User License)
USD 3999
PDF & Excel (Corporate License)
USD 4999

Add to Cart

The global HPV testing and PAP test market size reached USD 4.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.0 Billion by 2033, exhibiting a growth rate (CAGR) of 4.96% during 2025-2033.

Human papillomavirus (HPV) is a sexually transmitted infection (STI) that causes cancer of the cervix, oropharynx, penis, and vulva. It can be detected with the support of various tests and procedures, such as HPV and Papanicolaou (PAP) test. These assessments comprise microscopic observation of specimens and cervical, head and neck cancer screening. Amongst these, HPV tests are deployed for assessing the presence of human papillomavirus that precede the development of genital warts, whereas PAP tests are used for determining changes in the cell and the presence of abnormal cells in cervices.

HPV Testing and PAP Test Market Trends:

The increasing prevalence of cervical cancer, especially amongst the adult demographics. due to presence of papillomavirus is facilitating the need for novel, technologically advanced, and cost-effective HPV and PAP screening, which is one of the major factors primarily driving the market growth. In line with this, the introduction of machine-assisted, plasma- and cell-free deoxyribonucleic acid (DNA) screenings to detect and monitor the treatment response of HPV-infected cancers at the early phase is acting as another growth-inducing factor. This is further supported by the continuous clinical trials, developments, and product launches by key players, such as the easy-to-use home HPV screening test, on account of the sudden outbreak of coronavirus disease (COVID-19) pandemic, is providing them with a competitive edge in the market. Other factors, such as the rapid expansion in the healthcare sector and the numerous favorable initiatives undertaken by the government bodies and the non-governmental organizations (NGOs) for sensitizing people regarding the causes of cervical cancer and the benefits of having HPV and PAP tests are creating a positive outlook for the market.

Key Market Segmentation:

Breakup by Test Type:

  • HPV Test
  • Pap Test
  • Co-testing

Breakup by Product:

  • Instruments
  • Consumables
  • Services

Breakup by Application:

  • Cervical Cancer Screening
  • Vaginal Cancer Screening

Breakup by End User:

  • Hospitals and Clinics
  • Laboratories
  • Diagnostic Centers
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, AstraZeneca plc, Becton Dickinson and Company, Biocon Limited, bioMerieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., NURX Inc. (Thirty Madison Inc.), Qiagen N.V., Quest Diagnostics Incorporated, Seegene Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.How big is the global HPV testing and PAP test market?
  • 2.What is the expected growth rate of the global HPV testing and PAP test market during 2025-2033?
  • 3.What are the key factors driving the global HPV testing and PAP test market?
  • 4.What has been the impact of COVID-19 on the global HPV testing and PAP test market?
  • 5.What is the breakup of the global HPV testing and PAP test market based on the test type?
  • 6.What is the breakup of the global HPV testing and PAP test market based on the product?
  • 7.What is the breakup of the global HPV testing and PAP test market based on the application?
  • 8.What is the breakup of the global HPV testing and PAP test market based on the end user?
  • 9.What are the key regions in the global HPV testing and PAP test market?
  • 10.Who are the key players/companies in the global HPV testing and PAP test market?
Product Code: SR112025A5889

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global HPV Testing and PAP Test Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 HPV Test
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Pap Test
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Co-testing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Consumables
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Services
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Cervical Cancer Screening
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Vaginal Cancer Screening
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diagnostic Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Arbor Vita Corporation
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 AstraZeneca plc
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Becton Dickinson and Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Biocon Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 bioMerieux SA
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Danaher Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 F. Hoffmann-La Roche AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Hologic Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 NURX Inc. (Thirty Madison Inc.)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Qiagen N.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Quest Diagnostics Incorporated
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
    • 15.3.13 Seegene Inc.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
    • 15.3.14 Thermo Fisher Scientific Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis
Product Code: SR112025A5889

List of Figures

  • Figure 1: Global: HPV Testing and PAP Test Market: Major Drivers and Challenges
  • Figure 2: Global: HPV Testing and PAP Test Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: HPV Testing and PAP Test Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: HPV Testing and PAP Test Market: Breakup by Test Type (in %), 2024
  • Figure 5: Global: HPV Testing and PAP Test Market: Breakup by Product (in %), 2024
  • Figure 6: Global: HPV Testing and PAP Test Market: Breakup by Application (in %), 2024
  • Figure 7: Global: HPV Testing and PAP Test Market: Breakup by End User (in %), 2024
  • Figure 8: Global: HPV Testing and PAP Test Market: Breakup by Region (in %), 2024
  • Figure 9: Global: HPV Testing and PAP Test (HPV Test) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: HPV Testing and PAP Test (HPV Test) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: HPV Testing and PAP Test (Pap Test) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: HPV Testing and PAP Test (Pap Test) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: HPV Testing and PAP Test (Co-testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: HPV Testing and PAP Test (Co-testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: HPV Testing and PAP Test (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: HPV Testing and PAP Test (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: HPV Testing and PAP Test (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: HPV Testing and PAP Test (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: HPV Testing and PAP Test (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: HPV Testing and PAP Test (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: HPV Testing and PAP Test (Cervical Cancer Screening) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: HPV Testing and PAP Test (Cervical Cancer Screening) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: HPV Testing and PAP Test (Vaginal Cancer Screening) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: HPV Testing and PAP Test (Vaginal Cancer Screening) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: HPV Testing and PAP Test (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: HPV Testing and PAP Test (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: HPV Testing and PAP Test (Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: HPV Testing and PAP Test (Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: HPV Testing and PAP Test (Diagnostic Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: HPV Testing and PAP Test (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: HPV Testing and PAP Test (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: HPV Testing and PAP Test (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: North America: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: North America: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: United States: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: United States: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Canada: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Canada: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Asia-Pacific: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Asia-Pacific: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: China: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: China: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Japan: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Japan: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: India: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: India: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: South Korea: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: South Korea: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Australia: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Australia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Indonesia: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Indonesia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Others: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Europe: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Europe: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Germany: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Germany: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: France: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: France: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: United Kingdom: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: United Kingdom: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Italy: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Italy: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Spain: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Spain: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Russia: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Russia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Others: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Latin America: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Latin America: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Brazil: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Brazil: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Mexico: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Mexico: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Middle East and Africa: HPV Testing and PAP Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Middle East and Africa: HPV Testing and PAP Test Market: Breakup by Country (in %), 2024
  • Figure 81: Middle East and Africa: HPV Testing and PAP Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Global: HPV Testing and PAP Test Industry: SWOT Analysis
  • Figure 83: Global: HPV Testing and PAP Test Industry: Value Chain Analysis
  • Figure 84: Global: HPV Testing and PAP Test Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: HPV Testing and PAP Test Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: HPV Testing and PAP Test Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 3: Global: HPV Testing and PAP Test Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 4: Global: HPV Testing and PAP Test Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: HPV Testing and PAP Test Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: HPV Testing and PAP Test Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: HPV Testing and PAP Test Market: Competitive Structure
  • Table 8: Global: HPV Testing and PAP Test Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!